Two batches – 235012A and 236011 – contain a solvent which in tests has been found to contain traces of Staphylococcus aureus.
None of the contaminated samples of the Norvartis Menjugate Kit were distributed in the UK but, as a precaution, the MHRA has recalled both batches.
An MHRA spokesman said: ‘These batches of vaccine have been withdrawn to ensure that there are no grounds for anyone to be concerned.’
Nurses are advised to reassure any patient or parent with concerns that other meningitis vaccines and other batches of Menjugate are not affected by this recall. But if a parent has concerns, they should discuss this with their doctor, the MHRA said.
In a statement, Novartis said it was investigating how the solvent came to be contaminated with the bacteria. The company said it had no evidence that any other products containing aluminium-hydroxide solvents were affected.
Need to keep ahead of nursing news and clinical developments? Let us help. Get a comprehensive round-up delivered free to your inbox every day. Simply click here, log in and select 'Daily news alert'